Evidence map›Paper›PMID 37829730›Full record

ArticleFrontiers in nutrition2023

Ketogenic effects of medium chain triglycerides containing formula and its correlation to breath acetone in healthy volunteers: a randomized, double-blinded, placebo-controlled, single dose-response study.

Kentaro Nakamura, Keisuke Hagihara, Naoko Nagai, Ryuichiro Egashira, Mariko Takeuchi, Mai Nakano, Hitomi Saito, Misaki Moriguchi, Satoko Tonari, Hisako Fujii and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in nutrition, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Instrumental evaluation of the effect of oral medium-chain triglycerides oil on paroxysmal exercise-induced dyskinesia in GLUT1 deficiency syndrome.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Kentaro NakamuraCo-Creation Center, Meiji Holdings Co., Ltd., Tokyo, Japan.
Keisuke HagiharaDepartment of Advanced Hybrid Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Naoko NagaiDivision of Nutritional Management, Osaka University Hospital, Osaka, Japan.
Ryuichiro EgashiraDepartment of Advanced Hybrid Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Mariko TakeuchiDepartment of Advanced Hybrid Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Mai NakanoDepartment of Advanced Hybrid Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Hitomi SaitoDepartment of Advanced Hybrid Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Misaki MoriguchiDepartment of Advanced Hybrid Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Satoko TonariDepartment of Advanced Hybrid Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Hisako FujiiDepartment of Drug and Food Evaluation, Osaka City University Graduate School of Medicine, Osaka, Japan.
Akimitsu MiyakeDepartment of Medical Innovation, Osaka University Hospital, Osaka, Japan.
Yusuke OmaeCo-Creation Center, Meiji Holdings Co., Ltd., Tokyo, Japan.
Kinya AshidaCo-Creation Center, Meiji Holdings Co., Ltd., Tokyo, Japan.
Osaka University · JPMeiji (Japan) · JPOsaka University Hospital · JPOsaka City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The efficacy of low-carbohydrate, high-fat diets, such as ketogenic diets, for cancer patients is of research interest. We previously demonstrated the efficacy of the ketogenic diet in a case study in which medium-chain triglycerides (MCTs) or MCT-containing formula (ketogenic formula) was used as a supplement to increase blood ketone bodies. However, little is known about the amounts needed to induce ketogenic effects and about the usefulness of monitoring of breath acetone. To investigate the pharmacokinetics of MCTs and their metabolites, blood ketone bodies and breath acetone, 24 healthy subjects received one of four single oral doses of the ketogenic formula (equivalent to 0, 10, 20, and 30 g of MCTs) under fasting conditions. Total blood ketone bodies, β-hydroxybutyrate, octanoic acid, and decanoic acid were increased in a dose-dependent manner. The ketogenic effect was considered to depend on octanoic and decanoic acids, because a positive correlation was observed between them. A strong positive correlation was also observed between total serum ketone bodies and breath acetone at each time points. Therefore, monitoring breath acetone levels seems a less invasive method to predict blood concentrations of ketone bodies during ketogenic diet therapy.

Indexed as

breath acetonedose responseketogenic dietmedium chain triglyceridessingle dose study

Identifiers

PMID37829730
PMCPMC10566634
OpenAlexW4387139804

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.